AEMPS Bulletin November 2022 on medicinal products for human use



This report outlines the medicines already assessed by the Spanish Agency for Medicines and Health Products (AEMPS), which are considered to be of greatest interest to healthcare professionals. These are positive technical opinions from this national regulatory body prior to the authorisation and placing on the market of the medicinal product, which will take place in a few months’ time.

Private zoneHoja de Validación
Reembolso de Gastos